Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older

Journal of Rheumatology

Volumn 34, Issue 3, 2007, Pages 469-473

  Simard, Julia F ^a   Mittleman, Murray A ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Diabetes; National Health and Nutrition Examination Survey III; Older persons; Rheumatoid arthritis

Indexed keywords

AURANOFIN; AUROTHIOMALATE; AZATHIOPRINE; C REACTIVE PROTEIN; CHLOROQUINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE SULFATE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; UNITED STATES;

EID: 33847669745     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
2. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001;50:2384-9.
3. Wollheim FA. Markers of disease in rheumatoid arthritis. Curr Opin Rheumatol 2000;12:200-4.
4. Taylor PC. Antibody therapy for rheumatoid arthritis. Curr Opin Pharmacol 2003;3:323-8.
5. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
6. Hilliquin P. Biological markers in inflammatory rheumatic diseases. Cell Mol Biol 1995;41:993-1006.
7. Richardson C, Emery P. Laboratory markers of disease activity. J Rheumatol 1996;23 Suppl 44:23-30.
8. Wollheim FA. Predictors of joint damage in rheumatoid arthritis. APMIS 1996;104:81-93.
9. del Rincon I, Williams K, Stern MP, Freeman GL Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
10. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002;4:R5.
11. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
12. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthritis Rheum 2002;46:2287-93.
13. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology Oxford 2003;42:292-7.
14. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40:1286-92.
15. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999;353:1649-52.
16. Crook MA, Tutt P, Pickup JC. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy. Diabetes Care 1996;45:881-5.
17. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003;48:917-26.
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Gavin JR, Alberti KGMM, Davidson MB, et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26:S5-S20.
20. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
21. National Center for Health Statistics. Laboratory procedures used for the Third National Health and Nutrition Examination Survey, 1988-1994. Atlanta, GA, and Hyattsville, MD: US Department of Health and Human Services; 1994.
22. National Center for Health Statistics. NHANES III Public-UseData Files Errata. Internet. Available from: http://www.cdc.gov/nchs/about/major/nhanes/ nhanes3/errata.htm. Accessed October 19, 2006.
23. Stata survey data. In: Stata reference manual, Release 8. College Station, TX: Stata Press; 2003.
24. Mohadjer L, Montaquila J, Waksberg J, et al. National Health and Nutrition Examination Survey III: Weighting and estimation methodology, executive summary. Hyattsville, MD: National Center for Health Statistics; 1996.